ESR2 and colorectal carcinoma: Given that CRC affects more men than women and the incidence is reduced by hormone replacement therapy in ERβ-positive postmenopausal women [11], a protective role in the prevention and/or progression of CRC has been attributed to estrogen and ERβ [10,12,13].